News
Many doctors recommend routine follow-up tests for cancer patients after they’ve completed a course of treatment, with the ...
Buoyed by four $1 million donations, Trump's inaugural festivities reeled in $5.3 million from Washington state residents and businesses.
Novavax shows financial improvement but faces vaccine challenges. Read why I rated NVAX stock as 'Hold' and what risks and ...
Under emergency use, vaccines can be removed even after a health emergency is considered to be over. Full approval from the FDA means a product can stay on the market even after a health emergency ...
After a 20% cut to the FDA’s workforce, biotechs and pharmas are bracing for delays. But the impacts won’t be consistent.
11h
Stocktwits on MSNNovavax Tops Weekly Retail Buzz Spike Amid FDA Trial Drama, COVID-19 Vaccine Approval HopesNovavax, Inc. (NVAX) shares jumped nearly 12.6% over the past week, leading to a surge in retail investor chatter following ...
12h
NewsNation on MSNBill proposes making Ivermectin available over the counter in PARep. Jacob Banta said in the bill's memo that Ivermectin is "a very safe drug that has been used by millions of people ...
Former National Institutes of Health Director Dr. Francis Collins, who abruptly left his NIH research lab in February, fears ...
Confusion over the FDA delay in granting full approval to Novavax’s Covid-19 vaccine deepened over the weekend, with possible ...
Andreas Kalcker’s appearance at the conference highlights how dangerous alternative health claims have been growing during Trump’s second term in office.
The FDA has discussed with vaccine-maker Novavax the need for an additional trial of its COVID-19 vaccine as a post-approval ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results